Literature DB >> 30456640

The Collagenase of the Bacterium Clostridium histolyticum in the Treatment of Irradiation-Induced Capsular Contracture.

Yannick F Diehm1,2, Christoph Hirche1, Martin R Berger3, Jörg Heil4, Michael Golatta4, Dimitra Kotsougiani1, Bohdan Pomahac2, Ulrich Kneser1, Sebastian Fischer5,6.   

Abstract

BACKGROUND: Irradiation therapy is an important pillar in the treatment of breast cancer. However, it can trigger capsular fibrosis, the most significant complication of implant-based breast reconstruction. As collagen is the main component of fibrotic capsules, the collagenase of the bacterium Clostridium histolyticum poses a potential treatment option for this pathological condition.
METHODS: Thirty-six rats received miniature silicone implants on their backs. On day 1, the implant sites of two groups were irradiated with 10 Gy. On day 120, one irradiated group received collagenase injections into the implant pockets (n = 12). Non-irradiated (n = 12) and irradiated capsules (n = 12) were injected with plain solvent solution serving as controls. Data were analyzed by means of in vivo imaging, histology, immunohistochemistry and gene expression analysis.
RESULTS: Compared with both controls, the injection of collagenase led to significantly thinner capsules. This was verified by in vivo imaging and histology. Although irradiation provoked alterations in capsule collagen structure and vessel wall thickness, the application of collagenase resulted in a significant reduction of collagen density. This was accompanied by an up-regulation of VEGF-A gene expression. Of note, hematoma formation inside the implant pocket occurred in two cases after collagenase injection.
CONCLUSIONS: The collagenase of the bacterium Clostridium histolyticum is effective in degrading irradiation-induced capsular fibrosis around silicone implants. Hematoma formation occurred most likely because of irradiation-induced alterations in vessel wall architecture and capsule vascularization. Further studies need to be performed to address the clinical safety of this novel treatment option.

Entities:  

Keywords:  Breast augmentation; Capsular contracture; Capsular fibrosis; Collagenase of the bacterium C. histolyticum; Silicone implants

Mesh:

Substances:

Year:  2018        PMID: 30456640     DOI: 10.1007/s00266-018-1267-y

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  3 in total

1.  The collagenase of the bacterium Clostridium histolyticum does not favor metastasis of breast cancer.

Authors:  Yannick Fabian Diehm; Katharina Marstaller; Anna-Maria Seckler; Martin Reinhold Berger; Michael Zepp; Matthias Martin Gaida; Julia Thomé; Dimitra Kotsougiani-Fischer; Ulrich Kneser; Sebastian Fischer
Journal:  Breast Cancer       Date:  2022-02-07       Impact factor: 4.239

2.  Oral doxycycline prevents skin-associated adverse effects induced by injectable collagenase in a rodent model of capsular contracture around silicone implants.

Authors:  Yannick F Diehm; Dimitra Kotsougiani-Fischer; Elena Porst; Valentin Haug; Laura C Siegwart; Daniel Overhoff; Ulrich Kneser; Sebastian Fischer
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

Review 3.  Current role of the collagenase Clostridium histolyticum in Dupuytren's disease treatment.

Authors:  Rafael Sanjuan-Cervero
Journal:  Ir J Med Sci       Date:  2019-11-11       Impact factor: 1.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.